Lidokainklorid Belupo

Lidocaine Hydrochloride, the active ingredient in Lidokainklorid Belupo, is a local anesthetic presented as a sterile injectable solution for epidural, infiltration, and intramuscular use. It provides reversible nerve impulse blockade for pain management during minor surgical procedures, epidural analgesia, and intramuscular pain control.

GNH USA supplies Lidokainklorid Belupo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring EU‑standard quality and reliable global distribution.

Lidokainklorid Belupo, containing lidocaine hydrochloride, is used in the local anesthetic pathway for pain control.

- Epidural analgesia: provides regional pain relief during labor, surgery or postoperative periods. - Infiltration anesthesia: produces localized numbness for minor surgical or dental procedures. - Intramuscular injection for pain management: delivers rapid analgesia in acute musculoskeletal pain or procedural settings.

Lidokainklorid Belupo may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Transient burning or stinging at the injection site - Mild dizziness or light‑headedness - Nausea or vomiting - Tinnitus (ringing in the ears)

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Cardiac arrhythmias or conduction disturbances - Methemoglobinemia - Central nervous system toxicity, including seizures or loss of consciousness

When using Lidokainklorid Belupo, consider the following precautions.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular status: avoid high doses in patients with heart block, arrhythmias, or severe cardiac disease. - Dose limits: adhere to recommended maximum dose for the specific route and patient weight. - Concurrent CNS depressants: use caution when combined with other agents that may lower seizure threshold. - Pregnancy and lactation: evaluate risk‑benefit; limited data are available. - Store at ambient temperature: keep in original container, protect from light and moisture.

Lidokainklorid Belupo can interact with several drug classes; monitoring is essential.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase systemic toxicity. - Beta‑blockers (e.g., propranolol): can enhance cardiac effects of lidocaine. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma lidocaine concentrations.

Moderate Interactions (Monitor Closely): - Other local anesthetics: cumulative toxicity risk. - Diuretics (e.g., furosemide): may reduce plasma protein binding, increasing free lidocaine. - General anesthetics (e.g., propofol, volatile agents): additive CNS depression may occur.